Gal-9 was shown to induce apoptosis in Th1 and Th17 cells via the Tim-3 pathway [7,8] and is thought to contribute to the activation of tumor immunity and suppression of the autoimmune response via 4-1BB (CD137) [9]. Here, LGALS9 is linked to neoplasm.